Clinical Trial Update: Lactobacillus Reuteri for the Treatment of Infantile Colic: [Phase 3]

View source ↗

Summary

Phase 3 trial of Lactobacillus reuteri for infantile colic has completed. The sponsor is the Medical University of Warsaw.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Colic

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Infantile Colic, Crying | Phase 3 | Status: COMPLETED